(Circulation. 1995;91:955-961.)
© 1995 American Heart Association, Inc.
Articles |
Cardiac Involvement in Mitochondrial Diseases
A Study on 17 Patients With Documented Mitochondrial DNA Defects
From the First (R.A., M.M., S.N., H.T.) and Third (M.N., I.H., M.S., M.O.) Departments of Internal Medicine, Faculty of Medicine, Kagoshima University, Kagoshima, Japan.
Correspondence to Hiromitsu Tanaka, MD, First Department of Internal Medicine, Faculty of Medicine, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890, Japan.
Background Mutations of mitochondrial DNA have been demonstrated as causes of human mitochondrial diseases. While these disorders typically involve multiple organs, the effect of mitochondrial mutations on the heart has not been systematically studied.
Methods and Results We studied mitochondrial mutations and cardiac changes in 17 patients with Kearns-Sayre syndrome; ocular myopathy; myoclonus epilepsy with ragged red fibers (MERRF); and mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS). Cardiac involvement was evaluated by chest radiograph, ECG, His-bundle electrogram, and echocardiogram. All 3 patients with Kearns-Sayre syndrome had large deletions of mitochondrial DNA and disturbances in cardiac conduction. ECG abnormalities were found in 2 of 6 patients with ocular myopathy who showed large deletions of mitochondrial DNA. All 3 patients with MERRF had an A-to-G mutation at nucleotide position 8344; 2 had cardiomegaly, asymmetrical septal hypertrophy, and diffuse hypokinesis of the left ventricle. One patient with asymmetrical septal hypertrophy developed dilated cardiomyopathy 2 years later. All 5 patients with MELAS had an A-to-G mutation at nucleotide position 3243, and 2 had symmetrical left ventricular hypertrophy with or without abnormal wall motion.
Conclusions The clinical features of cardiac involvement in mitochondrial diseases vary in the different subgroups of these disorders. Particular mitochondrial mutations can cause characteristic cardiac abnormalities.
Key Words: genetics • hypertrophy • myocardium • heart block • mitochondria
This article has been cited by other articles:
 |
|
 |
|
  J. Kienhofer, D. J. F. Haussler, F. Ruckelshausen, E. Muessig, K. Weber, D. Pimentel, V. Ullrich, A. Burkle, and M. M. Bachschmid Association of mitochondrial antioxidant enzymes with mitochondrial DNA as integral nucleoid constituents FASEB J, July 1, 2009; 23(7): 2034 - 2044. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S M Ware, N El-Hassan, S G Kahler, Q Zhang, Y-W, E Miller, B Wong, R L Spicer, W J Craigen, B A Kozel, et al. Infantile cardiomyopathy caused by a mutation in the overlapping region of mitochondrial ATPase 6 and 8 genes J. Med. Genet., May 1, 2009; 46(5): 308 - 314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Tsutsui, S. Kinugawa, and S. Matsushima Mitochondrial oxidative stress and dysfunction in myocardial remodelling Cardiovasc Res, February 15, 2009; 81(3): 449 - 456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Marsh, P. O'Callaghan, and P. Smith The humble electrocardiogram Practical Neurology, January 1, 2008; 8(1): 46 - 59. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Chen, P. Jungsuwadee, M. Vore, D. A. Butterfield, and D. K. St. Clair Collateral Damage in Cancer Chemotherapy: Oxidative Stress in Nontargeted Tissues Mol. Interv., June 1, 2007; 7(3): 147 - 156. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. R. Madamanchi and M. S. Runge Mitochondrial Dysfunction in Atherosclerosis Circ. Res., March 2, 2007; 100(4): 460 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.A.M. Majamaa-Voltti, S. Winqvist, A. M. Remes, U. Tolonen, J. Pyhtinen, S. Uimonen, M. Karppa, M. Sorri, K. Peuhkurinen, and K. Majamaa A 3-year clinical follow-up of adult patients with 3243A>G in mitochondrial DNA Neurology, May 23, 2006; 66(10): 1470 - 1475. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ikeuchi, H. Matsusaka, D. Kang, S. Matsushima, T. Ide, T. Kubota, T. Fujiwara, N. Hamasaki, A. Takeshita, K. Sunagawa, et al. Overexpression of Mitochondrial Transcription Factor A Ameliorates Mitochondrial Deficiencies and Cardiac Failure After Myocardial Infarction Circulation, August 2, 2005; 112(5): 683 - 690. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Scaglia, J. A. Towbin, W. J. Craigen, J. W. Belmont, E. O. Smith, S. R. Neish, S. M. Ware, J. V. Hunter, S. D. Fernbach, G. D. Vladutiu, et al. Clinical Spectrum, Morbidity, and Mortality in 113 Pediatric Patients With Mitochondrial Disease Pediatrics, October 1, 2004; 114(4): 925 - 931. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. V. Patel, M. Arad, I. P. G. Moskowitz, C. T. Maguire, D. Branco, J. G. Seidman, C. E. Seidman, and C. I. Berul Electrophysiologic characterization and postnatal development of ventricular pre-excitation in a mouse model of cardiachypertrophy and Wolff-Parkinson-White syndrome J. Am. Coll. Cardiol., September 3, 2003; 42(5): 942 - 951. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Guery, G. Choukroun, L.-H. Noel, P. Clavel, A. Rotig, S. Lebon, P. Rustin, C. Bellane-Chantelot, B. Mougenot, J.-P. Grunfeld, et al. The Spectrum of Systemic Involvement in Adults Presenting with Renal Lesion and Mitochondrial tRNA(Leu) Gene Mutation J. Am. Soc. Nephrol., August 1, 2003; 14(8): 2099 - 2108. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L Bindoff Mitochondria and the heart Eur. Heart J., February 1, 2003; 24(3): 221 - 224. [Full Text] [PDF]
|
|
|
|
|
|
D Holmgren, H Wahlander, B.O Eriksson, A Oldfors, E Holme, and M Tulinius Cardiomyopathy in children with mitochondrial disease: Clinical course and cardiological findings Eur. Heart J., February 1, 2003; 24(3): 280 - 288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Momiyama, Y. Suzuki, M. Ohtomo, Y. Atsumi, K. Matsuoka, F. Ohsuzu, and M. Kimura Cardiac Autonomic Nervous Dysfunction in Diabetic Patients With a Mitochondrial DNA Mutation: Assessment by heart rate variability Diabetes Care, December 1, 2002; 25(12): 2308 - 2313. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D N Nan, M Fernandez-Ayala, J Infante, P Matorras, and J Gonzalez-Macias Progressive cardiomyopathy as manifestation of mitochondrial disease Postgrad. Med. J., May 1, 2002; 78(919): 298 - 299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Y. Li, D. Chen, S. C. Watkins, and A. M. Feldman Mitochondrial Abnormalities in Tumor Necrosis Factor-{alpha}-Induced Heart Failure Are Associated With Impaired DNA Repair Activity Circulation, November 13, 2001; 104(20): 2492 - 2497. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Spellberg, R. M. Carroll, E. Robinson, and E. Brass mtDNA Disease in the Primary Care Setting Arch Intern Med, November 12, 2001; 161(20): 2497 - 2500. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Nishikai, A. Shimada, S. Iwanaga, T. Yamada, S. Yamada, T. Ishii, H. Maruyama, and T. Saruta Progression of Cardiac Dysfunction in a Case of Mitochondrial Diabetes: A case report Diabetes Care, May 1, 2001; 24(5): 960 - 961. [Full Text]
|
|
|
|
|
|
T. Ide, H. Tsutsui, S. Hayashidani, D. Kang, N. Suematsu, K.-i. Nakamura, H. Utsumi, N. Hamasaki, and A. Takeshita Mitochondrial DNA Damage and Dysfunction Associated With Oxidative Stress in Failing Hearts After Myocardial Infarction Circ. Res., March 16, 2001; 88(5): 529 - 535. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Momiyama, Y. Suzuki, F. Ohsuzu, Y. Atsumi, K. Matsuoka, and M. Kimura Left Ventricular Hypertrophy and Diastolic Dysfunction in Mitochondrial Diabetes Diabetes Care, March 1, 2001; 24(3): 604 - 605. [Full Text]
|
|
|
|
|
|
J. Marin-Garcia, M. J Goldenthal, and G. W Moe Mitochondrial pathology in cardiac failure Cardiovasc Res, January 1, 2001; 49(1): 17 - 26. [Full Text] [PDF]
|
|
|
|
|
|
R. S. Williams Canaries in the Coal Mine : Mitochondrial DNA and Vascular Injury From Reactive Oxygen Species Circ. Res., May 12, 2000; 86(9): 915 - 916. [Full Text] [PDF]
|
|
|
|
|
|
D. Jarreta, J. Orus, A. Barrientos, O. Miro, E. Roig, M. Heras, C. T Moraes, F. Cardellach, and J. Casademont Mitochondrial function in heart muscle from patients with idiopathic dilated cardiomyopathy Cardiovasc Res, March 1, 2000; 45(4): 860 - 865. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Momiyama, Y. Suzuki, F. Ohsuzu, Y. Atsumi, K. Matsuoka, and M. Kimura Maternally transmitted susceptibility to non-insulin-dependent diabetes mellitus and left ventricular hypertrophy J. Am. Coll. Cardiol., April 1, 1999; 33(5): 1372 - 1378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Arbustini, M. Diegoli, R. Fasani, M. Grasso, P. Morbini, N. Banchieri, O. Bellini, B. Dal Bello, A. Pilotto, G. Magrini, et al. Mitochondrial DNA Mutations and Mitochondrial Abnormalities in Dilated Cardiomyopathy Am. J. Pathol., November 1, 1998; 153(5): 1501 - 1510. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y Okajima, Y Tanabe, M Takayanagi, and H Aotsuka A follow up study of myocardial involvement in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) Heart, September 1, 1998; 80(3): 292 - 295. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. H. Lee, N. Doliba, M. Osbakken, M. Oz, and D. Mancini Improvement of myocardial mitochondrial function after hemodynamic support with left ventricular assist devices in patients with heart failure J. Thorac. Cardiovasc. Surg., August 1, 1998; 116(2): 344 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Schwartz, G. F. Cox, A. E. Lin, M. S. Korson, A. Perez-Atayde, R. V. Lacro, and S. E. Lipshultz Clinical Approach to Genetic Cardiomyopathy in Children Circulation, October 15, 1996; 94(8): 2021 - 2038. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. Kosinski, M. Mull, H. Lethen, and R. Topper Evidence for Cardioembolic Stroke in a Case of Kearns-Sayre Syndrome Stroke, October 1, 1995; 26(10): 1950 - 1952. [Abstract] [Full Text]
|
|
|
|
|
|
R. S. Williams Cardiac Involvement in Mitochondrial Diseases, and Vice Versa Circulation, February 15, 1995; 91(4): 1266 - 1268. [Full Text]
|
|